pub 30-day FRN

Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Blood and Tissue Safety and
Availability
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:

The U.S. Department of
Health and Human Services is hereby
giving notice that the Advisory
Committee on Blood and Tissue Safety
and Availability (ACBTSA) will hold a
virtual meeting. The meeting will be
open to the public. For this meeting, the
committee will discuss and vote on a
recommendation pertaining to a
proposed update to the 2020 Public
Health Service (PHS) Guideline for
Assessing Solid Organ Donors and
Monitoring Transplant Recipients for
Human Immunodeficiency Virus,
Hepatitis B Virus, and Hepatitis C Virus
Infection. The following question will
be posed to the committee: Does the
available data support exempting solid
organ transplant candidates who are ≤10
years of age at the time of transplant
(and who have received postnatal
infectious disease testing) from the
recommendation for HIV, Hepatitis B
virus, and Hepatitis C virus testing
during the hospital admission for
transplant but prior to anastomosis of
the first organ?
DATES: The meeting will take place
virtually on Wednesday, December 1,
2021 from approximately 11:00 a.m.–
3:00 p.m. Eastern Time (ET). Meeting
times are tentative and subject to
change. The confirmed times and
agenda items for the meeting will be
posted on the ACBTSA web page at
https://www.hhs.gov/oidp/advisorycommittee/blood-tissue-safetyavailability/meetings/2021-12-01/
index.html when this information
becomes available.
FOR FURTHER INFORMATION CONTACT:
James Berger, Designated Federal Officer
for the ACBTSA; Office of Infectious
Disease and HIV/AIDS Policy, Office of
the Assistant Secretary for Health,
Department of Health and Human
Services, Mary E. Switzer Building, 330
C Street SW, Suite L600, Washington,
DC 20024. (202) 795–7608 or Email:
ACBTSA@hhs.gov.
SUPPLEMENTARY INFORMATION: The
ACBTSA is a discretionary Federal
advisory committee. The Committee is
governed by the provisions of the
Federal Advisory Committee Act
(FACA), Public Law 92–463, as

lotter on DSK11XQN23PROD with NOTICES1

SUMMARY:

VerDate Sep<11>2014

17:03 Nov 15, 2021

Jkt 256001

amended (5 U.S.C. App), which sets
forth standards for the formation and
use of advisory committees. On the day
of the meeting, please go to https://
www.hhs.gov/live/index.html to view
the meeting. The public will have an
opportunity to present their views to the
ACBTSA by submitting a written public
comment. Comments should be
pertinent to the meeting discussion.
Persons who wish to provide written
public comment should review
instructions at https://www.hhs.gov/
oidp/advisory-committee/blood-tissuesafety-availability/meetings/2021-12-01/
index.html and respond by midnight
November 26, 2021, ET. Written public
comments will be accessible to the
public on the ACBTSA web page prior
to the meeting.
ACBTSA functions to provide advice
to the Secretary through the Assistant
Secretary for Health on a range of policy
issues to include: (1) Identification of
public health issues through
surveillance of blood and tissue safety
issues with national survey and data
tools; (2) identification of public health
issues that affect availability of blood,
blood products, and tissues; (3) broad
public health, ethical, and legal issues
related to the safety of blood, blood
products, and tissues; (4) the impact of
various economic factors (e.g., product
cost and supply) on safety and
availability of blood, blood products,
and tissues; (5) risk communications
related to blood transfusion and tissue
transplantation; and (6) identification of
infectious disease transmission issues
for blood, organs, blood stem cells and
tissues. The Committee has met
regularly since its establishment in
1997.
Dated: October 27, 2021.
James J. Berger,
Designated Federal Officer, Advisory
Committee on Blood and Tissue Safety and
Availability, Office of Infectious Disease and
HIV/AIDS Policy.
[FR Doc. 2021–24895 Filed 11–15–21; 8:45 am]
BILLING CODE 4150–28–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Division of
Extramural Research and Training
(DERT) Extramural Grantee Data
Collection (National Institute of
Environmental Health Sciences)
AGENCY:

National Institutes of Health,

HHS.

PO 00000

Frm 00077

Fmt 4703

Sfmt 4703

ACTION:

63405

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:

Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Kristianna
Pettibone, Evaluator, Program Analysis
Branch, NIEHS, NIH, 530 Davis Dr.,
Room 3064, Morrisville, NC 20560, or
call non-toll-free number 984–287–3303
or Email your request, including your
address to: pettibonekg@niehs.nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on September 13, 2021,
Volume 86, Number 74, page 50897–
50898 and allowed 60-days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Institute of
Environmental Health Sciences
(NIEHS), National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: DERT
Extramural Grantee Data Collection,
0925–0757– REVISION—Expiration
Date 11/30/2021, National Institute of
Environmental Health Sciences
ADDRESSES:

E:\FR\FM\16NON1.SGM

16NON1

63406

Federal Register / Vol. 86, No. 218 / Tuesday, November 16, 2021 / Notices

(NIEHS), National Institutes of Health
(NIH).
Need and Use of Information
Collection: In order to make informed
management decisions about its
research programs and to demonstrate
the outputs, outcomes and impacts of its
research programs NIEHS will collect,
analyze and report on data from
extramural grantees who are currently
receiving funding or who have received
funding in the past on topics such as: (1)

Key scientific outcomes achieved
through the research and the impact on
the field of environmental health
science; (2) Contribution of research
findings to program goals and
objectives; (3) Satisfaction with the
program support received; (4)
Challenges and benefits of the funding
mechanism used to support the science;
and (5) Emerging research areas and
gaps in the research.

Information gained from this primary
data collection will be used in
conjunction with data from grantee
progress reports and presentations at
grantee meetings to inform internal
programs and new funding initiatives.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
740.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Total
annual burden
hours

NICHD Grantee ...............................................................................................
NIDCD Grantee ...............................................................................................
NIMH Grantee ..................................................................................................
NINDS Grantee ................................................................................................
NCI Grantee .....................................................................................................
NIEHS Grantee (long form) .............................................................................
NIEHS Grantee (short form) ............................................................................

200
200
200
200
400
200
240

1
1
1
1
1
1
1

30/60
30/60
30/60
30/60
30/60
30/60
10/60

100
100
100
100
200
100
40

Total ..........................................................................................................

........................

1,640

........................

740

Jane M. Lambert,
Project Clearance Liaison, National Institute
of Environmental Health Sciences, National
Institutes of Health.
[FR Doc. 2021–24920 Filed 11–15–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting

lotter on DSK11XQN23PROD with NOTICES1

Average
burden per
response
(in hours)

Number of
responses per
respondent

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Nephrology
and Hemodialysis Small Business Activities.
Date: November 23, 2021.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.

VerDate Sep<11>2014

17:03 Nov 15, 2021

Jkt 256001

Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Santanu Banerjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2106,
Bethesda, MD 20892, (301) 435–5947,
banerjees5@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 10, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–24997 Filed 11–15–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.

PO 00000

Frm 00078

Fmt 4703

Sfmt 4703

The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Research Education
Program (R25 Clinical Trial Not Allowed).
Date: December 10, 2021.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health,5601 Fishers Lane, Room 3G21,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Robert C. Unfer, Ph.D.,
Scientific Review Officer, Scientific Review
Program,Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health,5601
Fishers Lane, Room 3G21, Rockville, MD
20852, (240) 669–5035,robert.unfer@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)

E:\FR\FM\16NON1.SGM

16NON1